Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Drug detection kit

A technology for detecting kits and drugs, applied in biological testing, measuring devices, material inspection products, etc., can solve the problems of high cost, complicated process, and no color development of C line, and achieve simple operation, simple preparation process, and low cost Effect

Inactive Publication Date: 2017-09-15
BOZHOU CITY THE NEW HEALTH TECH CO LTD
View PDF12 Cites 13 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

However, the existing drug detection test cards can only detect the presence of drugs qualitatively, and cannot achieve quantitative or semi-quantitative detection, or can achieve quantitative detection of drugs, but the process is extremely complicated and the cost is high
[0005] In the prior art, the multi-drug compound detection method is to combine highly specific antibody-antigen reaction with immunocolloidal gold chromatography technology, but the defect is that the detection test paper is affected by the color intensity of the C-line during the compound detection. The influence of the color intensity makes it impossible to semi-quantitatively compare the detection results of different antigens although the presence of multiple drugs in the same urine sample can be detected
In addition, the defect of the prior art drug detection test paper is that the color intensity of the C-line is affected by the color intensity of the T-line, which must be one dark and one shallow, and the function of the C-line is only to judge whether the chromatography reaches the control area. However, if the C line does not develop color, there may be other situations besides the invalid test. For example, when the drug content in the test sample exceeds the detection threshold, the colloidal gold-labeled antibody is completely reacted, resulting in the detection being effective but the C line is still ineffective. Color rendering

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0036] Take MDMA (ecstasy) detection kit as an example to describe in detail.

[0037] A methylenedioxyamphetamine detection kit, comprising a test paper and a matching plastic box, the test paper is sequentially lapped and pasted by a sample pad, a polyester fiber membrane, a nitrocellulose membrane, and a water-absorbing filter paper Formed on a PVC plastic sheet, the polyester fiber membrane is coated with colloidal gold-labeled MDMA antibody (i.e. detection antibody) and rabbit IgG antibody (i.e. control line antibody), so The nitrocellulose membrane includes a detection area (T line) coated with methylenedioxyamphetamine antigen and a quality control area (C line) coated with goat anti-rabbit IgG polyclonal antibody (i.e. the second antibody). Wire).

[0038] The methylenedioxyamphetamine antibody-colloidal gold marker is dried at 37°C for 4-24 hours, the colloidal gold coating concentration is OD15-OD35, and the coating amount is 0.5-1.5ul / cm .

[0039]Among them, the...

Embodiment 2

[0047] Take the morphine detection kit as an example to describe in detail.

[0048] A morphine detection kit, comprising a test paper and a matching plastic box, the test paper is composed of a sample pad, a polyester fiber membrane, a nitrocellulose membrane, and a water-absorbing filter paper which are successively lapped and pasted on a PVC plastic sheet, and the poly Colloidal gold-labeled rabbit anti-morphine monoclonal antibody (i.e. detection antibody) and mouse IgG antibody (i.e. control line antibody) are coated on the ester fiber membrane, and the nitrocellulose membrane includes a detection area coated with morphine antigen (T line) and the quality control area (C line) coated with goat anti-mouse IgG polyclonal antibody (ie, secondary antibody).

[0049] The morphine antibody-colloidal gold marker is dried at 37°C for 4-24 hours, the colloidal gold coating concentration is OD15-OD35, and the coating amount is 0.5-1.5ul / cm.

[0050] Wherein, the selection of morph...

Embodiment 3

[0059] Taking MDMA detection as an example to illustrate the preparation process of MDMA detection kit, it includes the following steps:

[0060] S1. Coating the MDMA antibody-colloidal gold marker on the polyester fiber membrane;

[0061] The colloidal gold is prepared according to the trisodium citrate reduction method (Frens, 1973). The preparation process is simple, and the prepared gold particles are uniform. Wherein, the colloidal gold particles are selected to be 40nm colloidal gold particles.

[0062] The labeling method of the colloidal gold of the MDMA antibody is: the colloidal gold and the MDMA antibody are mixed in the most appropriate proportion, and the colloidal gold and the dimethylene The dioxyamphetamine antibody forms stable colloidal particles, which are purified and condensed to form the methylenedioxyamphetamine antibody-colloidal gold label.

[0063] Specifically, dilute the methylenedioxyamphetamine antibody-colloidal gold to OD25 (optional range: OD...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention provides a drug detection kit and its preparation process, which combines highly specific antibody antigen reaction with immune colloidal gold chromatography technology, improves on the basis of this prior art, and detects antibody in colloidal gold labeling At the same time, mark the control line antibody, and correspondingly point the second antibody on the membrane at the quality control area (C line) for color reaction with the colloidal gold-labeled control line antibody, so as to ensure that the C line will always develop color, and the color will develop The degree will not change, so it can be judged whether one or more drugs are contained by observing whether the detection area (T line) is colored, and one or more drugs can be semi-quantitatively compared by observing the degree of color development of the T line . The drug detection kit has the characteristics of qualitative and semi-quantitative comparison of drugs, and also has the characteristics of rapidity, sensitivity, easy operation, low cost, and no need for professional detection.

Description

technical field [0001] The invention relates to the technical field of biology and new medicine, in particular to a drug joint detection kit, which is suitable for screening in drug rehabilitation centers, hospitals, military conscription, high-risk population censuses, special industries and physical examinations for recruitment, and food inspections by health and epidemic prevention departments. Wait. Background technique [0002] At present, the gold standard method is mainly used for urine testing in drug testing, which is characterized by fast, convenient, portable, and high accuracy. The commonly used methods for the determination of single drugs in urine are: monoclonal antibody monolithic qualitative method, thin-layer chromatography, gas chromatography, and gas-mass spectrometry detection method, but these methods exist to varying degrees. Cross-reaction, many interference factors and complex pre-treatment process are insufficient. Gas-mass spectrometry (GC-MS) de...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): G01N33/558G01N33/531
CPCG01N33/94G01N33/531G01N33/558G01N33/946G01N33/9466G01N33/948
Inventor 熊良钟熊清爵王梓光陈敏王振
Owner BOZHOU CITY THE NEW HEALTH TECH CO LTD
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products